Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fresenius Medical Care Deutschland GmbH
It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins. Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is not associated with a clinically relevant development of adverse events.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
signed informed consent
patients of either sex aged ≥ 18 years
stable chronic dialysis patients undergoing a 3x/week high-flux dialysis for at least three months
patients without planned or predictable changes within diet, anticoagulation and medication regimen
You may not be if
pregnancy or lactation or woman in child bearing age without effective contraception
planned surgeries or hospital stay within the next 9 weeks
use of catheter as vascular access for dialysis
severe comorbidities not allowing to follow the study protocol
